Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Alkermes (ALKS) over the last 16 years, with Q3 2025 value amounting to -$28.2 million.

  • Alkermes' Change in Accured Expenses rose 6515.03% to -$28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.9 million, marking a year-over-year increase of 16533.67%. This contributed to the annual value of -$58.0 million for FY2024, which is 35193.19% down from last year.
  • Per Alkermes' latest filing, its Change in Accured Expenses stood at -$28.2 million for Q3 2025, which was up 6515.03% from $53.3 million recorded in Q2 2025.
  • In the past 5 years, Alkermes' Change in Accured Expenses registered a high of $68.2 million during Q3 2021, and its lowest value of -$81.0 million during Q3 2024.
  • Over the past 5 years, Alkermes' median Change in Accured Expenses value was $2.9 million (recorded in 2025), while the average stood at $1.1 million.
  • Over the last 5 years, Alkermes' Change in Accured Expenses had its largest YoY gain of 111945.39% in 2024, and its largest YoY loss of 851619.94% in 2024.
  • Quarter analysis of 5 years shows Alkermes' Change in Accured Expenses stood at -$4.0 million in 2021, then soared by 177.13% to $3.1 million in 2022, then plummeted by 34.05% to $2.1 million in 2023, then skyrocketed by 1119.45% to $25.0 million in 2024, then crashed by 212.93% to -$28.2 million in 2025.
  • Its Change in Accured Expenses stands at -$28.2 million for Q3 2025, versus $53.3 million for Q2 2025 and $2.9 million for Q1 2025.